Chemoinformaics analysis of SCILLARENIN-3-O-RHAMNOSIDE
| Molecular Weight | 530.658 | nRot | 3 |
| Heavy Atom Molecular Weight | 488.322 | nRig | 33 |
| Exact Molecular Weight | 530.288 | nRing | 6 |
| Solubility: LogS | -3.324 | nHRing | 2 |
| Solubility: LogP | 2.37 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 84.5213 |
| nHD | 4 | BPOL | 48.2107 |
| QED | 0.439 |
| Synth | 5.052 |
| Natural Product Likeliness | 2.731 |
| NR-PPAR-gamma | 0.624 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.031 |
| HIA | 0.879 |
| CACO-2 | -4.991 |
| MDCK | 0.0000184 |
| BBB | 0.337 |
| PPB | 0.940046 |
| VDSS | 1.999 |
| FU | 0.0523468 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.795 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.79 |
| CYP2c9-inh | 0.041 |
| CYP2c9-sub | 0.366 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.753 |
| CYP3a4-inh | 0.115 |
| CYP3a4-sub | 0.266 |
| CL | 2.549 |
| T12 | 0.046 |
| hERG | 0.05 |
| Ames | 0.07 |
| ROA | 0.982 |
| SkinSen | 0.015 |
| Carcinogencity | 0.694 |
| EI | 0.004 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.788 |
| Antiviral | Yes |
| Prediction | 0.855874 |